Abstract: The present invention relates to bacteria which specifically target infarcted tissue and use thereof. The present invention provides a selective infarcted tissue-targeting bacterium for the first time, and can be used in selectively delivering drugs to the infarcted tissue or in selectively imaging the infarcted tissue. The infarcted tissue-targeting bacterium of the present invention can finish treatments by using antibiotics, and therefore, have remarkable advantages as compared to gene therapy using recombinant viruses. The infarcted tissue-targeting bacterium of the present invention have a significantly high affinity and specificity to infarcted myocardium or infarcted brain, thereby significantly reducing undesired transfections in the organs or tissues other than the heart. The gene expression by the infarcted tissue-targeting bacterium of the present invention in infarcted myocardium or infarcted brain is remotely controllable.

Abstract: Disclosed are a transistor structure for a display and an organic light emitting display device. The transistor structure includes: a voltage line positioned in one direction and configured to supply voltage to pixels; and two or more transistors which share one of drains and sources which are formed integrally with the voltage line and respectively include the other of the drains and sources which are individually formed and connected with different nodes directly or through a connection pattern.

Abstract: Disclosed are thienopyrimidinone derivatives as antagonists that act on metabotropic glutamate receptor subtype 1. The thienopyrimidinone derivatives show pharmacological activity against metabotropic glutamate receptor-related diseases, including pain, such as neuropathic pain and migraine, psychiatric diseases, such as anxiety disorder and schizophrenia, urinary incontinence, and neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. Also disclosed are methods for preparing the thienopyrimidinone derivatives, and pharmaceutical compositions containing the thienopyrimidinone derivatives as active ingredients.

Abstract: Provided are a liquid crystal device, a composition capable of forming a liquid crystal layer, a method of manufacturing the liquid crystal device, a system for manufacturing the liquid crystal device, and a use of the liquid crystal device. The liquid crystal device is a device capable of exhibiting, for example, a normally white or black mode, which may exhibit a high contrast ratio and be driven with a low driving voltage, and exhibit excellent durability such as thermal stability. Such a liquid crystal device may be applied to various optical modulators such as a smart window, a window protective film, a flexible display device, an active retarder for displaying 3D images, or a viewing angle control film.

Abstract: Provided are a liquid crystal device, a composition capable of forming a liquid crystal layer, a method of manufacturing the liquid crystal device, a system for manufacturing the liquid crystal device, and a use of the liquid crystal device. The liquid crystal device is a device capable of exhibiting, for example, a normally white or black mode, exhibiting a high contrast ratio, driven with a low driving voltage, and exhibiting excellent durability such as thermal stability. Such a liquid crystal device may be applied to various optical modulators such as a smart window, a window protective film, a flexible display device, an active retarder for displaying 3D images, or a viewing angle control film.

Abstract: Provided are a liquid crystal device, a composition capable of forming a liquid crystal layer, a method of manufacturing the liquid crystal device, a system for manufacturing the liquid crystal device, and a use of the liquid crystal device. The liquid crystal device is a device capable of exhibiting, for example, a normally transparent or black mode, exhibiting a high contrast ratio, being driven with a low driving voltage, and exhibiting excellent durability such as thermal stability. Such a liquid crystal device may be applied to various optical modulators such as a smart window, a window protective film, a flexible display device, an active retarder for displaying 3D images, or a viewing angle control film.

Abstract: The present application relates to a liquid crystal cell, a method for preparing a liquid crystal cell and a display device. An exemplary liquid crystal cell may be applied to various types of display devices so as to control a viewing angle or light transmittance of the display device.

Abstract: The present invention provides: a method for manufacturing an insulated conductive pattern, wherein a conductive film and an insulation layer pattern are formed on a substrate, and the insulation layer pattern is reformed to cover a conductive pattern after formation of the conductive pattern by etching the conductive film using the insulation layer pattern as a mask; and a laminate manufactured thereby. According to the present invention, the number of processes is sharply reduced in comparison with the existing processes, and economic efficiency can be greatly improved.

Abstract: The present invention provides an organic light emitting display device that includes a display panel in which an organic light emitting diode and a driving circuit are disposed in each pixel area of a first pixel and a second pixel which are certain pixels among a plurality of pixels, a floating pattern insulated from at least one of a first electrode of the organic light emitting diode of the first pixel and a first electrode of the organic light emitting diode of the second pixel is formed in the display panel, or a connection pattern for electrically connecting the first electrode of the organic light emitting diode of the first pixel with the first electrode of the organic light emitting diode of the second pixel is formed.

Abstract: A liquid crystal device, a precursor composition, a method of manufacturing a liquid crystal device, an apparatus of manufacturing a liquid crystal device, and use of the liquid crystal device are provided. A device capable of being driven at a low driving voltage can be provided. The device can be realized so that the device can be driven in a normally transparent mode or a normally black mode. Also, the device has other excellent characteristics such as a contrast ratio. Such a liquid crystal device can be applied to various light modulation devices such as smart windows, window-protecting films, flexible display devices, active retarders for displaying 3D images, or viewing angle-adjusting films.

Abstract: Novel benzoarylureido compounds and a use thereof for prevention and/or treatment of the neurodegenerative brain disease are provided. The neurodegenerative brain diseases may include Alzheimer's disease, dementia, Parkinson's disease, stroke, amyloidosis, Pick's disease, Lou Gehrig's disease, Huntington's disease, Creutzfeld-Jakob disease, and the like.

Abstract: The present invention relates to a method for preparing tetrabenazine (TBZ) and dihydrotetrabenazine (DTBZ), and more specifically to a method for preparing tetrabenazine (TBZ) and dihydrotetrabenazine (DTBZ) by using simple and short reaction processes of using 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline and 4-methyl-2-(3-(trimethylsilyl)prop-1-ene-2-yl)pentane as starting materials to sequentially perform an alkylation reaction, an Aza-Prins cyclization reaction in the presence of an oxidant and an oxidation reaction.

Abstract: Provided is a 2-(substituted ethynyl)quinoline derivative having an mGluR5 antagonistic activity and pharmaceutically acceptable salts thereof. The compound of the present invention can be useful as a medicament for treating and preventing mGluR5 receptor-mediated diseases such as Alzheimer's disease, senile dementia, Parkinson's disease, L-DOPA-induced dyskinesia, Huntington's chorea, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, anxiety disorder, depression, neuropathic pain, drug dependence, fragile X syndrome, autism, migraine and gastroesophageal reflux disease (GERD).

Abstract: The present application relates to a liquid crystal cell, a method for preparing a liquid crystal cell and a display device. An exemplary liquid crystal cell may be applied to various types of display devices so as to control a viewing angle or light transmittance of the display device.

Abstract: The present application relates to a liquid crystal cell, a method for preparing a liquid crystal cell and a display device. An exemplary liquid crystal cell may be applied to various types of display devices so as to control a viewing angle or light transmittance of the display device.

Abstract: Disclosed are thienopyrimidinone derivatives as antagonists that act on metabotropic glutamate receptor subtype 1. The thienopyrimidinone derivatives show pharmacological activity against metabotropic glutamate receptor-related diseases, including pain, such as neuropathic pain and migraine, psychiatric diseases, such as anxiety disorder and schizophrenia, urinary incontinence, and neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease. Also disclosed are methods for preparing the thienopyrimidinone derivatives, and pharmaceutical compositions containing the thienopyrimidinone derivatives as active ingredients.

Abstract: Provided is a 2-(substituted ethynyl)quinoline derivative having an mGluR5 antagonistic activity and pharmaceutically acceptable salts thereof. The compound of the present invention can be useful as a medicament for treating and preventing mGluR5 receptor-mediated diseases such as Alzheimer's disease, senile dementia, Parkinson's disease, L-DOPA-induced dyskinesia, Huntington's chorea, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, anxiety disorder, depression, neuropathic pain, drug dependence, fragile X syndrome, autism, migraine and gastroesophageal reflux disease (GERD).

Abstract: A memory device includes a memory cell array including a plurality of memory blocks, each memory block including a plurality of memory cells, a plurality of word lines coupled to rows of the plurality of memory cells, a plurality of bit lines coupled to columns of the plurality of memory cells, and a control unit controlling an erase operation so that erase data is simultaneously written in the plurality of memory cells corresponding to an erase unit. A first erase mode may include a first erase unit and a first erase data pattern. A second erase mode may include a second erase unit and a second erase pattern. At least one of the first and second erase units and the first and second erase data patterns are different.

Abstract: Provided are a benzimidazole derivative modulating mitochondrial functions and having pharmaceutical activity as a neuro-protective agent, and a pharmaceutical composition including the compound as an active ingredient.

Abstract: The present invention relates to a method for controlling land surface temperature using stratospheric airships and a reflector. In the method for controlling land surface temperature using stratospheric airships and a reflector, four corners are connected to a lower end of support lines coupled to be disposed vertically downward from a plurality of airships, and sunlight is reflected by a reflector unfolded into a tetragonal shape in the air, wherein the reflecting surface of the reflector plate is maintained at an angle to remain perpendicular to an incident angle of sunlight to shield the land surface from incident sunlight.